Edgewise Therapeutics (EWTX) Net Equity Issued and Repurchased (2022 - 2025)
Edgewise Therapeutics (EWTX) posted Net Equity Issued and Repurchased of $262000.0 for Q2 2025, down 99.89% sequentially from $239.1 million in Q1 2024.
Edgewise Therapeutics (EWTX) Net Equity Issued and Repurchased (2022 - 2025) Analysis & Trends
Edgewise Therapeutics has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at $262000.0 in Q2 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $262000.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $262000.0 (down 99.89% YoY) and the FY2025 annual result came in at $187.4 million, down 21.65% from the prior year.
- Net Equity Issued and Repurchased declined to $262000.0 in Q2 2025 per EWTX's latest filing, from $239.1 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $239.1 million in Q1 2024 and troughed at -$555000.0 in Q4 2022.
- A 3-year average of $79.6 million and a median of $262000.0 in 2025 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Edgewise Therapeutics | 4.76 Bn | 4.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 262,000.00 |
| Jun 30, 2025 | 262,000.00 |
| Mar 31, 2024 | 239.15 Mn |
| Mar 31, 2024 | 239.15 Mn |
| Dec 31, 2022 | -555,000.00 |
| Dec 31, 2022 | -555,000.00 |